| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $216.41M | $154.07M | $143.72M | $145.60M | $130.71M |
| R&D | $184.70M | $119.45M | $113.76M | $112.50M | $100.07M |
| SG&A | $31.71M | $34.63M | $29.97M | $33.10M | $30.65M |
| Operating Income | -$216.41M | -$154.07M | -$143.72M | -$145.60M | -$130.71M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | – |
| Net Income | -$206.69M | -$138.20M | -$134.24M | -$141.95M | -$130.32M |
| EPS (basic) | -1.3400 | -1.0100 | -1.7700 | -2.6000 | -3.4000 |
| EPS (diluted) | -1.3400 | -1.0100 | -1.7700 | -2.6000 | -3.4000 |
| Shares (diluted) | $155.11M | $137.40M | $75.67M | $54.67M | $38.32M |